We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antimalarial drugs

News List

FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs worldpharmanews
April 26, 2020
The U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems.
Limited supply of antimalarial drugs may prevent use against COVID-19, say doctors europeanpharmaceuticalreview
April 08, 2020
An open letter from doctors highlights that although chloroquine and hydroxychloroquine are strong candidates to fight COVID-19, there is a limited supply.
Malaria resistance to first-line antimalarial drugs spreading rapidly: The Lancet expresspharma
July 25, 2019
Researchers from Wellcome Sanger Institute and University of Oxford found that descendants of one multi-drug resistant malaria strain are replacing local parasite populations